David A. Siegel Nls Pharmaceutics Ltd. Transaction History

Two Sigma Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.82 - $1.76 $18,696 - $40,128	-22,800 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.11 - $2.56 $4,995 - $11,520	-4,500 Reduced 16.48%	22,800 $25,000
Q3 2021 Nov 15, 2021	BUY	$2.29 - $3.14 $37,785 - $51,810	16,500 Added 152.78%	27,300 $68,000
Q2 2021 Aug 16, 2021	BUY	$2.91 - $4.12 $31,428 - $44,496	10,800 New	10,800 $34,000

8.16M

Ticker NLSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,349,900
Market Cap $6.46M
Description
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.